Drugs to Market: Creating Value and Advantage in the Pharmaceutical Industry: 5 (Technology, Innovation, Entrepreneurship and Competitive Strategy, 5) - Image 1

£72.99

Pergamon Press Drugs to Market: Creating Value and Advantage in the Pharmaceutical Industry: 5 (Technology, Innovation, Entrepreneurship and Competitive Strategy, 5)

Name: Drugs to Market: Creating Value and Advantage in the Pharmaceutical Industry: 5 (Technology, Innovation, Entrepreneurship and Competitive Strategy, 5)
Brand: Pergamon Press
Price: 72.99 GBP
Availability: InStock

Advertising

This is the most expensive it has ever been. Walk away.

£73 today · previous high £73 · all-time low £63

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days · 81 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £63 (55 days, 67.9%)

Price range: £63 - £73

Price levels: 2 different prices over 81 days

Description

The development and marketing of drugs since the Second World War offers an exemplary demonstration of the impact of technology on competitiveness in a major industry. While focusing primarily on the market in the USA, this study examines also the activities of European firms, their contribution to the industry's technological evolution and the impact of their entry into the US market. The main concern of the book, however, is to examine all the elements which go to make up the evolving landscape of competition, and their interaction. Thus, the effects of technological change are viewed in the context of changes in the legal and regulatory environment, and in competitive practice. For both the market as a whole and the individual firm this analysis illustrates how competitive positions actually emerge as a result of such interactions. Consistent with this wider view, both the technological and the non-technological competencies of firms are discussed, and the concept of core competence is used extensively to show how individual firms developed and maintained their competitive strengths, as the industry moved from deep-tank fermentation through to the first decade of biotechnology. The final chapter highlights the key role of biotechnology in shaping the future of the industry, at a time of increased regulation and accelerating market driven change.

Product Specifications

Brand: Pergamon Press
Format: hardcover
ASIN: 0080425593
Category: Books > Subjects > Business, Finance & Law > Sales & Marketing > Advertising
Domain: Amazon UK
Release Date: 14 June 1996
Listed Since: 15 December 2006

Barcode

No barcode data available

Pergamon Press Drugs to Market: Creating Value and Advantage in the Pharmaceutical Industry: 5 (Technology, Innovation, Entrepreneurship and Competitive Strategy, 5)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Science and Innovation: The US Pharmaceutical Industry during the 1980s

Competition and Marketing Strategies in the Pharmaceutical Industry (RLE Marketing) (Routledge Library Editions: Marketing)

Developing Strategies for Competitive Advantage: 5 (The Best of Long Range Planning, 5)

Knowledge Accumulation and Industry Evolution: The Case of Pharma-Biotech

Management of Technology: Perception and opportunities

Knowledge Accumulation and Industry Evolution: The Case of Pharma-Biotech

Information Technology and Industrial Competitiveness: How IT Shapes Competition

Managing Biotechnology: From Science to Market in the Digital Age

Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in Law and Health)

R&D, Innovation and Competitiveness in the European Chemical Industry

Market-Oriented Technology Management: Innovating for Profit in Entrepreneurial Times

Global Issues in Pharmaceutical Marketing

Changing Innovation in the Pharmaceutical Industry: Globalization and New Ways of Drug Development

The Economics of Competition: The Race to Monopoly

医薬品産業2026：規模から創薬力へ: 競争構造の転換と研究プラットフォームの持続力 (ファーマセットDATABOOKシリーズ)

Creating Value through Skill-Based Strategy and Entrepreneurial Leadership: 8 (Technology, Innovation, Entrepreneurship and Competitive Strategy, 8)

Pharmaceutical Medicine, Biotechnology and European Law

Innovation, Human Capital and Trade Competitiveness: How Are They Connected and Why Do They Matter? (Innovation, Technology, and Knowledge Management)

Innovation, Alliances, and Networks in High-Tech Environments (Routledge Studies in Global Competition)

Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries: The Commercialization of Intellectual Property

R&D, Innovation and Competitiveness in the European Chemical Industry (Social Indicators Research S)

Innovation, Human Capital and Trade Competitiveness: How Are They Connected and Why Do They Matter? (Innovation, Technology, and Knowledge Management)

Competitiveness Food Industry

Strategy and Performance: Achieving Competitive Advantage in the Global Marketplace